We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-11.76%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$151M
Cap. Flow
+$238K
Cap. Flow %
0.08%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$235K
2
RAPT
RAPT Therapeutics
RAPT
+$3.36K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$43.7B
$109M 36.3%
4,577,840
– –
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$91M 30.31%
18,136,735
– –
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$53.1M 17.67%
335,078
+21
+0% +$3.36K
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.44B
$21M 7%
3,568,181
– –
TNYA icon
5
Tenaya Therapeutics
TNYA
$163M
$18.9M 6.29%
9,400,290
– –
SRZN icon
6
Surrozen
SRZN
$282M
$5.48M 1.82%
627,653
+11,111
+2% +$235K
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.84M 0.61%
172,373
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q4 2022 Portfolio in Review

As of Q4 2022, Column Group held 7 positions worth $300M, down 34% from $452M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to Surrozen in Q4 2022, an estimated $235K increase.
  • Column Group's ten largest holdings make up 100% of its $300M portfolio in Q4 2022.
  • Column Group opened 0 new positions and closed 0 in Q4 2022.
  • Column Group's portfolio value fell 34% quarter-over-quarter to $300M.

Based on Column Group's 13F filing for Q4 2022, filed 13 Feb 2023.